Bile duct issues may shorten cancer treatment, study finds

NCT ID NCT07101874

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at medical records of 729 people in Japan with biliary tract cancer that could not be removed by surgery. Researchers wanted to see if bile duct problems during first treatment affected how long patients could stay on that treatment. The study did not test any new drug or procedure, but simply observed what happened in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

biliary tract cancer Biliary Tract Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILIARY TRACT CANCER

Contacts and locations

Locations

Research Site

Aichi, Japan
Research Site

Chiba, Japan
Research Site

Ehime, Japan
Research Site

Fukuoka, Japan
Research Site

Fukushima, Japan
Research Site

Hokkaido, Japan
Research Site

Hyōgo, Japan
Research Site

Ishikawa, Japan
Research Site

Kagawa, Japan
Research Site

Kanagawa, Japan
Research Site

Kochi, Japan
Research Site

Kyoto, Japan
Research Site

Miyagi, Japan
Research Site

Nara, Japan
Research Site

Okayama, Japan
Research Site

Osaka, Japan
Research Site

Ōita, Japan
Research Site

Saitama, Japan
Research Site

Shizuoka, Japan
Research Site

Tochigi, Japan
Research Site

Tokyo, Japan
Research Site

Wakayama, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.